2 Se r io us Sk in C on ta c t:

H e a lt h
1 Wa sh w ith a d isin fe cta n t so a p a n d co ve r t h e co n ta m ina te d skin w ith a n a n ti-b a cte rial cre a m . Se e k m e d ical a tt e n tio n .
F ir e 1 In ha la tio n:
2 0 If in h a led , re m o ve t o f re sh a ir. I f n o t b re a th ing , g ive a rtificial re sp irat ion . If b re a th ing is d ifficu lt, g ive o xyg e n . Ge t m e d ical
R e a c t iv it y 0
a tt e n tio n .
P e rs o n a l E Se r io us I nh a la tio n: N o t a va ila b le.
P ro t e c t io n
In ge s tio n:
Material Safety Data Sheet D o N OT in d u ce vo m iting u n less d irect e d t o d o so b y m e d ical p e rso n n e l. N e ve r g ive a n yth ing b y m o u th t o a n u n co n sciou s
p e rso n . L o o se n t igh t clot h ing su ch a s a co lla r, tie , b e lt o r w a istb a n d . Ge t m e d ical a tt e n tio n if sym p to m s a p p e a r.
Am m oniu m sulfat e MSD S
Se r io us I ng e s tio n: N o t a va ila b le.
Section 1: Chemical Product and Company Identification
Pr od uc t N a m e : Am m o n ium su lfa te C on ta c t I nfo r m a tio n: Section 5: Fire and Explosion Data
C a ta lo g C od e s : SL A2 8 5 1 , SL A2 0 1 1 , SL A1 1 6 8 , SL A2 6 7 4 Sc ie nc e la b. c om , In c .
1 4 0 2 5 Sm ith R d . Fl a m m a bi li ty o f th e Pr od uc t: M a y b e co m b u stib le a t h igh t e m p e ra tu re .
C A S# : 7 7 8 3 -2 0 -2 H o u sto n , Te xa s 7 7 3 9 6 A uto -Ig ni tio n Te m pe r a tur e : N o t a va ila b le.
R TEC S: BS4 5 0 0 0 0 0 U S Sa les: 1 -8 0 0 -9 0 1 -7 2 4 7
Fl a s h Poi nts : C L OSED C U P: H igh e r t h a n 9 3 .3 C (2 0 0 F).
In te rn a tio n a l Sa les: 1 -2 8 1 -4 4 1 -4 4 0 0
TSC A : T SC A 8 (b ) in ve n to ry: Am m o n ium su lfa te
Ord e r O n lin e : Scien ce L a b .co m Fl a m m a bl e L im its : N o t a va ila b le.
C I# : N o t a va ila b le. Pr od uc ts o f C om bu s tio n: N o t a va ila b le.
C H EM TR EC (2 4 H R Em e r ge nc y T e le ph on e ), c a ll :
Sy no ny m : Su lfluric Acid , D iam m o n ium Sa lt 1 -8 0 0 -4 2 4 -9 3 0 0 Fi r e H a za r ds i n Pr e s e nc e o f Va r io us Su bs ta nc e s :
C he m ic a l N a m e :Am m o n ium Su lfa te Fla m m a b le in p re se n ce o f o xidizing m a te rials. Slig h tly f lam m a b le to f lam m a b le in p re se n ce o f h e a t.
In te r na tio na l C H EM TR EC , c a ll : 1 -7 0 3 -5 2 7 -3 8 8 7
Ex pl os io n H a za r ds i n Pr e s e nc e o f Va r io us Su bs ta nc e s :
C he m ic a l Fo r m ul a :(N H 4 )2 SO4 Fo r n on -e m e r ge nc y a s s is ta nc e , c a ll :1 -2 8 1 -4 4 1 -4 4 0 0
R isks o f e xp losio n o f th e p ro d u ct in p re se n ce o f m e ch a n ical im p a ct: N o t a va ila b le. R isks o f e xp losio n o f th e p ro d u ct in
p re se n ce o f sta tic d ischa rg e : N o t a va ila b le. Exp losive in p re se n ce o f o xidizing m a te rials.
Section 2: Composition and Information on Ingredients Fi r e F ig hti ng M e di a a nd I ns tr uc tio ns :
SM AL L F IR E: U se D R Y ch e m ical p o w d e r. L AR GE FI R E: U se w a te r sp ra y, fo g o r f o a m . D o n o t u se w a te r je t.
C om po s iti on :
Spe c ia l R e m a r k s o n Fi r e H a za r ds :
Name CAS # % b y W e ig ht A m ixtu re o f a m m o n ium su lfa te a n d p o ta ssium ch lora te d e co m p o se s w ith in ca n d e sce n ce w h e n h e a te d . Wh e n a little
Am m o n ium su lfa te 7 7 8 3 -2 0 -2 100 a m m o n ium su lfa te is a d d e d t o f u se d p o ta ssium n itrite , a vig o ro u s re a ctio n o ccu rs a tt e n d e d b y f lam e . N o n co m b u stib le. T h is
su b sta n ce itse lf d o e s n o t b u rn , b u t m a y d e co m p o se u p o n h e a tin g t o p ro d u ce co rro sive a n d /o r t o xic fu m e s.
To x ic ol og ic a l D a ta o n In gr e di e nts :Am m o n ium su lfa te : OR AL (L D 5 0 ): Acu te : 2 8 4 0 m g /kg [ R a t] . 6 4 0 m g /kg [ M o u se ]. Spe c ia l R e m a r k s o n Ex pl os io n H a za r ds :
If a ccide n tly m ixed w ith o xidize rs like p o ta ssium ch lora te , p o ta ssium n itra te o r p o ta ssium n itrite , th e re is a n e xp losio n h a za rd
d u ring f ire. A m ixtu re o f a m m o n ium su lfa te a n d a m m o n ium n itra te ca n e a sily b e e xp lod e d b y p o ta ssium o r so d ium -p o ta ssium
Section 3: Hazards Identification a llo y.

Pote nti a l A c ute H e a lth Effe c ts : H a za rd o u s in ca se o f skin co n ta ct (irrita n t), o f e ye co n ta ct (irrita n t), o f ing e stio n , o f inh a lat ion .

Pote nti a l C hr on ic H e a lth Effe c ts :

Section 6: Accidental Release Measures
C AR C IN OG EN IC EF FEC TS: N o t a va ila b le. M U TAG EN IC EF FEC TS: N o t a va ila b le. T ER ATO GEN IC EF FEC TS: N o t a va ila b le.
D EVEL OPM EN TAL T OXI C IT Y: N o t a va ila b le. R e p e a te d o r p ro lon g e d e xp o su re is n o t kn o w n t o a g g ra va te m e d ical co n d ition . Sm a ll Sp il l:
U se a p p ro p riat e t o o ls to p u t th e sp illed so lid in a co n ve n ien t w a ste d ispo sa l co n ta ine r. Fin ish clea n ing b y sp re a d ing w a te r o n
th e co n ta m ina te d su rfa ce a n d d ispo se o f a cco rd ing t o lo ca l a n d re g ion a l a u th o rity re q u irem e n ts.
Section 4: First Aid Measures
La r ge Sp il l:
Ey e C on ta c t: U se a sh o ve l to p u t th e m a te rial in to a co n ve n ien t w a ste d ispo sa l co n ta ine r. Fin ish clea n ing b y sp re a d ing w a te r o n t h e
C h e ck f o r a n d re m o ve a n y co n ta ct len se s. In ca se o f co n ta ct, im m e d iat e ly flu sh e ye s w ith p len ty o f w a te r f o r a t lea st 1 5 co n ta m ina te d su rfa ce a n d a llo w t o e va cu a te t h ro u g h t h e sa n ita ry syst e m .
m inu te s. C o ld w a te r m a y b e u se d . Ge t m e d ical a tt e n tio n .
Sk in C on ta c t:
In ca se o f co n ta ct, im m e d iat e ly flu sh skin w ith p len ty o f w a te r. C o ve r t h e irrita te d skin w ith a n e m o llien t. R e m o ve co n ta m ina te d Section 7: Handling and Storage
clot h ing a n d sh o e s. C o ld w a te r m a y b e u se d .W a sh clo th ing b e fo re re u se . Th o ro u g h ly clea n sh o e s b e fo re re u se . Ge t m e d ical
a tt e n tio n . Pr e c a uti on s :

p. 1 p. 2
Ke e p a w a y f ro m h e a t. Ke e p a w a y f ro m so u rce s o f ign ition . D o n o t ing e st. D o n o t b re a th e d u st. W e a r su ita b le p ro te ctive
clot h ing . In ca se o f insu ff icie n t ve n tilat ion , w e a r su ita b le re sp irat o ry e q u ipm e n t. I f ing e ste d , se e k m e d ical a d vice im m e d iat e ly Sta bi li ty : T h e p ro d u ct is sta b le.
a n d sh o w t h e co n ta ine r o r t h e la b e l. Avo id co n ta ct w ith skin a n d e ye s. Ke e p a w a y f ro m in co m p a tib les su ch a s o xidizing
In s ta bi li ty T e m pe r a tur e :N o t a va ila b le.
a g e n ts.
C on di tio ns o f I ns ta bi li ty : Exce ss h e a t, in co m p a tib le m a te rials.
Stor a ge : Ke e p co n ta ine r t igh tly clo se d . Ke e p co n ta ine r in a co o l, w e ll-ve n tilat e d a re a .
In c om pa tib il ity w ith v a r io us s ub s ta nc e s :
H igh ly re a ctive w ith o xidizing a g e n ts. R e a ctive w ith a lkalis.

Section 8: Exposure Controls/Personal Protection C or r os iv ity :N o n -co rro sive in p re se n ce o f g lass.

Spe c ia l R e m a r k s o n R e a c tiv ity :

Eng in e e r in g C on tr ol s :
In co m p a tib le w ith t h e f o llo w ing : Po ta ssium + a m m o n ium n itra te , p o ta ssium ch lora te , p o ta ssium n itra te , p o ta ssium n itrite ,
U se p ro ce ss e n closu re s, loca l e xh a u st ve n tilat ion , o r o th e r e n g ine e ring co n tro ls to ke e p a irbo rn e le ve ls b e low re co m m e n d e d
so d ium h yp o ch lorite , so d ium /p o ta ssium a llo y + a m m o n ium n itra te . Su b sta n ce sh o u ld n o t co n ta ct e ith e r zin c o r co p p e r b e a ring
e xp o su re lim its. If u se r o p e ra tio n s g e n e ra te d u st, f u m e o r m ist, u se ve n tilat ion t o ke e p e xp o su re t o a irbo rn e co n ta m ina n ts
m a te rials. R e a cts w ith a lkali to re lea se a m m o n ia.
b e low t h e e xp o su re lim it.
Spe c ia l R e m a r k s o n C or r os iv ity N
: o t a va ila b le.
Pe r s on a l Pr ote c tio n:
Sp lash g o g g les. L a b co a t. D u st re sp irat o r. Be su re t o u se a n a p p ro ve d /ce rtifie d re sp irat o r o r e q u ivale n t. G love s. Pol y m e r iza tio n: W ill n o t o ccu r.

Pe r s on a l Pr ote c tio n in C a s e o f a L a r ge Sp il l:
Sp lash g o g g les. F u ll su it. D u st re sp irat o r. Bo o ts. G love s. A se lf co n ta ine d b re a th ing a p p a ra tu s sh o u ld b e u se d t o a vo id
inh a lat ion o f th e p ro d u ct. Su g g e ste d p ro te ctive clo th ing m igh t n o t b e su ff icie n t; co n su lt a sp e cialist BEF OR E h a n d lin g t h is Section 11: Toxicological Information
p ro d u ct.
R ou te s o f En tr y : I n h a lat ion . In g e stio n .
Ex po s ur e L im its : N o t a va ila b le.
To x ic ity to A ni m a ls :Acu te o ra l to xicity (L D 5 0 ): 6 4 0 m g /kg [ M o u se ].

C hr on ic Effe c ts o n H um a ns : N o t a va ila b le.

Section 9: Physical and Chemical Properties Oth e r T ox ic Effe c ts o n H um a ns : H a za rd o u s in ca se o f skin co n ta ct (irrita n t), o f ing e stio n , o f inh a lat ion .

Phy s ic a l s ta te a nd a pp e a r a nc e :So lid . (C rysta ls so lid .) Spe c ia l R e m a r k s o n To x ic ity to A ni m a ls :

L o w e st Pu b lish e d L e th a l D o se /C o n c: L D L [ D o m e stic a n im a l - G o a t, Sh e e p ) - R o u te : Ora l; D o se : 3 5 0 0 m g /kg
Od or : O d o rless.
Spe c ia l R e m a r k s o n C hr on ic Effe c ts o n H um a ns :
Ta s te : N o t a va ila b le. It m a y b e a p o ssible m u ta g e n . It h a s b e e n t e ste d f o r m u ta g e n icity, b u t so f a r t e sts h a ve b e e n in co n clusive o r t e st inf o rm a tio n
M ol e c ul a r W e ig ht:1 3 2 .1 4 g /m o le h a s n o t b e e n m a d e a va ila b le.

C ol or : b ro w n ish g ra y t o w h ite Spe c ia l R e m a r k s o n oth e r T ox ic Effe c ts o n H um a ns :

Acu te Po te n tia l H e a lth Ef fe cts: Skin : C a u se s skin irrita tio n . Eye s: C a u se s e ye irrita tio n . In h a lat ion : M a y ca u se re sp irat o ry t ra ct
pH (1 % s ol n/ wa te r ): N o t a va ila b le. irrita tio n . In g e stio n : Wh e n in g e ste d , its o sm o larity ca n d ra w w a te r f ro m t h e b o d y in to t h e b o w e l, a ctin g a s a la xa tive . H o w e ve r,
if e n o u g h is a b so rb e d syst e m ically it m a y p ro d u ce Am m o n ia p o ison ing . Sym p to m s m a y in clud e g a stro int e stin a l (d ige stive )
B oi li ng Po in t: N o t a va ila b le.
tra ct irrita tio n w ith n a u se a , vo m iting , h yp e rm o tility, d iarrh e a . M a y a lso a ff e ct e ye s (M yd riasis), b e h a vior/ ce n tra l n e rvo u s syst e m
M e lti ng Po in t: 2 8 0 C (5 3 6 F) (so m n o len ce , tre m o r, co n vu lsio n s, m u scle co n tra ctio n o r sp a sticity), a n d re sp irat o ry syst e m (re sp irat o ry st im u lat ion , d ysp n e a ).
Also, w ith in g e stio n o f larg e d o se s o f Am m o n ium Su lfa te a rises th e p o ssibility o f su ff icie n t a b so rp tio n t o p ro d u ce d iure sis, a n
C r iti c a l Te m pe r a tur e :N o t a va ila b le.
e xce ssive d ischa rg e o f u rine , a n d kid n e y d a m a g e (re n a l tu b u lar d isord e r, a b n o rm a l re n a l fu n ctio n ). C h ro n ic Po te n tia l H e a lth
Spe c ifi c G r a v ity : 1 .7 7 (W a te r = 1 ) Eff e cts: O n e R u ssian o ccu p a tio n a l sta n d a rd st u d y d iscusse d ch ro n ic e xp o su re e ff e cts w h ich m a y in clud e ca rd iac co n tra ctio n ,
n e u ro to xicity, a n d h yp e rte n sion . Th is h a s n o t b e e n co n firm e d in o th e r a m m o n ium su lfa te e xp o se d w o rke rs.
Va po r Pr e s s ur e : N o t a p p lica b le.

Va po r D e ns ity : N o t a va ila b le.

Vol a til ity : N o t a va ila b le. Section 12: Ecological Information

Od or T hr e s ho ld : N o t a va ila b le. Ec oto x ic ity : N o t a va ila b le.
Wa te r /O il D is t. C oe ff.: N o t a va ila b le. B OD 5 a nd C OD : N o t a va ila b le.
Io ni c ity (i n Wa te r ): N o t a va ila b le. Pr od uc ts o f B io de gr a da tio n:
Po ssibly h a za rd o u s sh o rt te rm d e g ra d a tio n p ro d u cts a re n o t like ly. H o w e ve r, lon g t e rm d e g ra d a tio n p ro d u cts m a y a rise.
D is pe r s io n Pr op e r tie s :Se e so lub ility in w a te r.
To x ic ity o f th e Pr od uc ts o f B io de gr a da tio n: T h e p ro d u ct itse lf a n d its p ro d u cts o f d e g ra d a tio n a re n o t to xic.
Sol ub il ity :
So lub le in co ld w a te r. In so lub le in a ce to n e . Spe c ia l R e m a r k s o n the Pr od uc ts o f B io de gr a da tio n:N o t a va ila b le.

Section 10: Stability and Reactivity Data Section 13: Disposal Considerations

p. 3 p. 4
 n o liab ility re su lting f ro m its u se . U se rs sh o u ld m a ke t h e ir o w n in ve stig a tio n s t o d e te rm ine t h e su ita b ility o f th e in fo rm a tio n f o r
Wa s te D is po s a l: th e ir p a rticu lar p u rp o se s. In n o e ve n t sh a ll Scie n ce L a b .co m b e liab le fo r a n y cla im s, losse s, o r d a m a g e s o f a n y t h ird p a rty o r f o r
Wa ste m u st b e d ispo se d o f in a cco rd a n ce w ith f e d e ra l, st a te a n d lo ca l e n viron m e n ta l co n tro l re g u lat ion s. lost p ro fits o r a n y sp e cial, ind irect , incid e n ta l, co n se q u e n tia l o r e xe m p lary d a m a g e s, h o w so e ve r a risin g , e ve n if Scien ce L a b .co m
h a s b e e n a d vised o f th e p o ssibility o f su ch d a m a g e s.

Section 14: Transport Information

D OT C la s s ifi c a tio n: N o t a D OT co n tro lle d m a te rial (U n ite d St a te s).

Id e nti fic a tio n: N o t a p p lica b le.

Spe c ia l Pr ov is io ns fo r T r a ns po r t:N o t a p p lica b le.

Section 15: Other Regulatory Information

Fe de r a l a nd Sta te R e gu la tio ns :
R h o d e I slan d R TK h a za rd o u s su b sta n ce s: Am m o n ium su lfa te Pe n n sylvan ia R TK: Am m o n ium su lfa te F lorid a : Am m o n ium
su lfa te M a ssa ch u se tt s R TK: Am m o n ium su lfa te N e w Je rse y: Am m o n ium su lfa te T SC A 8 (b ) in ve n to ry: Am m o n ium su lfa te
Oth e r R e gu la tio ns : EI N EC S: Th is p ro d u ct is o n t h e Eu ro p e a n I n ve n to ry o f Existing C o m m e rcial C h e m ical Su b sta n ce s.

Oth e r C la s s ifi c a tio ns :

WH M IS (C a na da ): N o t co n tro lle d u n d e r W H M IS (C a n a d a ).

D SC L (EEC ):
R 1 6 - Exp losive w h e n m ixed w ith o xidizing su b sta n ce s. R 3 6 /3 8 - I rrita tin g t o e ye s a n d skin . S2 4 /2 5 - Avo id co n ta ct w ith skin a n d
e ye s.

H M IS (U .S. A .):

H e a lth H a za r d: 2

Fi r e H a za r d: 1

R e a c tiv ity : 0

Pe r s on a l Pr ote c tio n: E

N a tio na l Fi r e Pr ote c tio n A s s oc ia tio n (U .S. A .):

H e a lth : 2

Fl a m m a bi li ty : 1

R e a c tiv ity : 0

Spe c ifi c h a za r d:

Pr ote c tiv e Eq ui pm e nt:

Glo ve s. L a b co a t. D u st re sp irat o r. Be su re t o u se a n a p p ro ve d /ce rtifie d re sp irat o r o r e q u ivale n t. Sp lash g o g g les.

Section 16: Other Information

R e fe r e nc e s :N o t a va ila b le.

Oth e r Sp e c ia l C on s id e r a tio ns :N o t a va ila b le.

C r e a te d: 1 0 /1 0 /2 0 0 5 0 8 :1 4 PM

La s t U pd a te d: 0 5 /2 1 /2 0 1 3 1 2 :0 0 PM

Th e in fo rm a tio n a b o ve is b e lie ve d t o b e a ccu ra te a n d re p re se n ts th e b e st inf o rm a tio n cu rre n tly a va ila b le to u s. H o w e ve r, w e

m a ke n o w a rra n ty o f m e rch a n ta b ility o r a n y o th e r w a rra n ty, e xp re ss o r im p lie d , w ith re sp e ct to su ch in fo rm a tio n , a n d w e a ssu m e

p. 5 p. 6